Ignite Creation Date:
2024-05-05 @ 11:45 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00124527
Status:
COMPLETED
Last Update Posted:
2021-06-16
First Post:
2005-07-26
Brief Title:
Study of Irofulven Plus Capecitabine in Patients With Advanced Thyroid Cancer
Sponsor:
Eisai Inc
Organization:
Eisai Inc
Organization Data
Organization:
Eisai Inc
Class:
INDUSTRY
Study ID:
IROF-019
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Eisai Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None